Health TrialsbyHealthPanel

Clinical Study of mTOR Inhibitor as a Treatment for Grey Hair (Canities)

ConditionsCanitiesGrey Hair
Trial statusNot yet recruiting
Trial phasePhase 1, Phase 2
Trial typeInterventional
Biological sexAll
Age30-65
SponsorApplied Biology, Inc.

About this trial

Clinical Study to Assess the Safety and Efficacy of CS-002 (mTOR inhibitor) as a treatment for Canities (Grey Hair)

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age 30 to 65

Diagnosed with Grey Hair (Canities)

Willing and able to apply the treatment as directed, comply with study

Otherwise healthy

Disqualifiers

A medical history that may interfere with study objectives

Women who are pregnant, lactating, or planning to become pregnant during the study period

Subjects who have experienced a clinically important medical event within 90 days of the visit (e.g., stroke, myocardial infarction, etc)

Subjects who have known allergies to any excipient in CS-001

Trial design

Design model

Parallel

Treatments tested in this trial

  • CS-002

    Drug

    CS-002 Topical Treatment

  • Placebo Topical Solution

    Drug

    Placebo Topical Solution

Treatment groups

100 Participants
are divided into 2 treatment groups
Group A: CS-002Experimental treatment 1 intervention
Group B: PlaceboPlacebo comparator 1 intervention

Trial outcomes

Primary outcomes

1

Greying Severity Score

Greying Severity Score (GSS). Mild Greying score between 0-5, Moderate Greying score between 6-10 and Severe Greying score between 11-15

Time frame
Week [0,24]

Secondary outcomes

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Applied Biology, Inc.

Lead sponsor

Complex Science

Collaborator

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: